Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Carulli IP"'
Autor:
Yin S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.; Harvard Medical School, Boston, MA, United States., Klaeger S; Broad Institute of MIT and Harvard, Cambridge, MA, United States., Chea VA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA, United States., Carulli IP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA, United States., Rachimi S; Broad Institute of MIT and Harvard, Cambridge, MA, United States., Black KE; Harvard Medical School, Boston, MA, United States.; Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Boston, MA, United States., Filbin M; Harvard Medical School, Boston, MA, United States.; Department of Emergency Medicine, Massachusetts General Hospital, Boston, MA, United States., Hariri LP; Harvard Medical School, Boston, MA, United States.; Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Boston, MA, United States.; Department of Pathology, Massachusetts General Hospital, Boston, MA, United States., Knipe RS; Harvard Medical School, Boston, MA, United States.; Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Boston, MA, United States., Padera RF; Harvard Medical School, Boston, MA, United States.; Department of Pathology, Brigham and Women's Hospital, Boston, MA, United States., Stevens JD; Department of Pathology, Brigham and Women's Hospital, Boston, MA, United States., Lane WJ; Harvard Medical School, Boston, MA, United States.; Department of Pathology, Brigham and Women's Hospital, Boston, MA, United States., Carr SA; Broad Institute of MIT and Harvard, Cambridge, MA, United States., Wu CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.; Harvard Medical School, Boston, MA, United States.; Broad Institute of MIT and Harvard, Cambridge, MA, United States.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, United States., Kim EY; Harvard Medical School, Boston, MA, United States.; Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, MA, United States., Keskin DB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.; Harvard Medical School, Boston, MA, United States.; Broad Institute of MIT and Harvard, Cambridge, MA, United States.; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA, United States.; Section for Bioinformatics, Department of Health Technology, Technical University of Denmark, Lyngby, Denmark.; Department of Computer Science, Metropolitan College, Boston University, Boston, MA, United States.
Publikováno v:
Frontiers in immunology [Front Immunol] 2023 Oct 20; Vol. 14, pp. 1269335. Date of Electronic Publication: 2023 Oct 20 (Print Publication: 2023).
Autor:
Lee PC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Klaeger S; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA., Le PM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Korthauer K; Department of Statistics, University of British Columbia, Vancouver, British Columbia, Canada.; BC Children's Hospital Research Institute, Vancouver, British Columbia, Canada., Cheng J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Department of Molecular, Cellular and Biomedical Sciences, University of New Hampshire, Durham, New Hampshire, USA., Ananthapadmanabhan V; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Frost TC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Program in Virology, Graduate School of Arts and Sciences, Harvard University, Cambridge, Massachusetts, USA., Stevens JD; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA., Wong AY; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Iorgulescu JB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA., Tarren AY; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Chea VA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Carulli IP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Lemvigh CK; Section for Bioinformatics, Department of Health Technology, Technical University of Denmark, Lyngby, Denmark., Pedersen CB; Section for Bioinformatics, Department of Health Technology, Technical University of Denmark, Lyngby, Denmark.; Center for Genomic Medicine, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark., Gartin AK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Program in Virology, Graduate School of Arts and Sciences, Harvard University, Cambridge, Massachusetts, USA., Sarkizova S; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Department of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts, USA., Wright KT; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA., Li LW; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Nomburg J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Program in Virology, Graduate School of Arts and Sciences, Harvard University, Cambridge, Massachusetts, USA., Li S; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Huang T; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Liu X; Department of Cancer Biology and the Linde Program in Cancer Chemical Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Biological Chemistry and Molecular Pharmacology., Pomerance L; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Immunology, and., Doherty LM; Department of Cancer Biology and the Linde Program in Cancer Chemical Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Biological Chemistry and Molecular Pharmacology.; Department of Systems Biology and Laboratory of Systems Pharmacology, Harvard Medical School, Boston, Massachusetts, USA., Apffel AM; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA., Wallace LJ; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA., Rachimi S; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA., Felt KD; Center for Immuno-Oncology and., Wolff JO; Center for Immuno-Oncology and., Witten E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Zhang W; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Neuberg D; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Lane WJ; Harvard Medical School, Boston, Massachusetts, USA.; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA., Zhang G; Department of Computer Science, Metropolitan College, Boston University, Boston, Massachusetts, USA., Olsen LR; Section for Bioinformatics, Department of Health Technology, Technical University of Denmark, Lyngby, Denmark.; Center for Genomic Medicine, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark., Thakuria M; Harvard Medical School, Boston, Massachusetts, USA.; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Merkel Cell Carcinoma Center of Excellence, Dana-Farber/Brigham Cancer Center, Boston, Massachusetts, USA., Rodig SJ; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Center for Immuno-Oncology and., Clauser KR; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA., Starrett GJ; Laboratory of Cellular Oncology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland, USA., Doench JG; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA., Buhrlage SJ; Department of Cancer Biology and the Linde Program in Cancer Chemical Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Biological Chemistry and Molecular Pharmacology., Carr SA; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA., DeCaprio JA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Program in Virology, Graduate School of Arts and Sciences, Harvard University, Cambridge, Massachusetts, USA.; Merkel Cell Carcinoma Center of Excellence, Dana-Farber/Brigham Cancer Center, Boston, Massachusetts, USA., Wu CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA., Keskin DB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Section for Bioinformatics, Department of Health Technology, Technical University of Denmark, Lyngby, Denmark.; Department of Computer Science, Metropolitan College, Boston University, Boston, Massachusetts, USA.
Publikováno v:
The Journal of clinical investigation [J Clin Invest] 2022 Jul 01; Vol. 132 (13).
Autor:
Weingarten-Gabbay S; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Organismic and Evolutionary Biology, Harvard University, Cambridge, MA 02138, USA. Electronic address: shirawg@broadinstitute.org., Klaeger S; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA. Electronic address: sklaeger@broadinstitute.org., Sarkizova S; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Pearlman LR; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Chen DY; Department of Biochemistry, Boston University School of Medicine, Boston, MA, USA; National Emerging Infectious Diseases Laboratories, Boston University, Boston, MA, USA., Gallagher KME; Cellular Immunotherapy Program and Cancer Center, Massachusetts General Hospital, Charlestown, MA 02129, USA; Harvard Medical School, Boston, MA 02115, USA., Bauer MR; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Harvard Program in Biological and Biomedical Sciences, Harvard Medical School, Boston, MA 02115, USA., Taylor HB; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Dunn WA; Repertoire Immune Medicines, Cambridge, MA 02139, USA., Tarr C; Repertoire Immune Medicines, Cambridge, MA 02139, USA., Sidney J; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), La Jolla, CA 92037, USA., Rachimi S; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Conway HL; Department of Biochemistry, Boston University School of Medicine, Boston, MA, USA; National Emerging Infectious Diseases Laboratories, Boston University, Boston, MA, USA., Katsis K; Cellular Immunotherapy Program and Cancer Center, Massachusetts General Hospital, Charlestown, MA 02129, USA., Wang Y; Repertoire Immune Medicines, Cambridge, MA 02139, USA., Leistritz-Edwards D; Repertoire Immune Medicines, Cambridge, MA 02139, USA., Durkin MR; Repertoire Immune Medicines, Cambridge, MA 02139, USA., Tomkins-Tinch CH; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Organismic and Evolutionary Biology, Harvard University, Cambridge, MA 02138, USA., Finkel Y; Department of Molecular Genetics, Weizmann Institute of Science, Rehovot 76100, Israel., Nachshon A; Department of Molecular Genetics, Weizmann Institute of Science, Rehovot 76100, Israel., Gentili M; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Rivera KD; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Carulli IP; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA, USA., Chea VA; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA, USA., Chandrashekar A; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA., Bozkus CC; Department of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai Hospital, New York, NY, USA., Carrington M; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA; Basic Science Program, Frederick National Laboratory for Cancer Research in the Laboratory of Integrative Cancer Immunology, National Cancer Institute, Bethesda, MD, USA., Bhardwaj N; Department of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai Hospital, New York, NY, USA., Barouch DH; Harvard Medical School, Boston, MA 02115, USA; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA; Massachusetts Consortium on Pathogen Readiness, Boston, MA, USA., Sette A; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), La Jolla, CA 92037, USA; Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California, San Diego (UCSD), La Jolla, CA 92037, USA., Maus MV; Cellular Immunotherapy Program and Cancer Center, Massachusetts General Hospital, Charlestown, MA 02129, USA; Harvard Medical School, Boston, MA 02115, USA; Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, MA 02139, USA; Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, USA., Rice CM; Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY 10065, USA., Clauser KR; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Keskin DB; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA, USA; Health Informatics Lab, Metropolitan College, Boston University, Boston, MA, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Pregibon DC; Repertoire Immune Medicines, Cambridge, MA 02139, USA., Hacohen N; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, USA; Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA., Carr SA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Abelin JG; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Saeed M; Department of Biochemistry, Boston University School of Medicine, Boston, MA, USA; National Emerging Infectious Diseases Laboratories, Boston University, Boston, MA, USA. Electronic address: msaeed1@bu.edu., Sabeti PC; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Organismic and Evolutionary Biology, Harvard University, Cambridge, MA 02138, USA; Massachusetts Consortium on Pathogen Readiness, Boston, MA, USA; Department of Immunology and Infectious Disease, Harvard T.H. Chan School of Public Health, Boston, MA, USA; Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA.
Publikováno v:
Cell [Cell] 2021 Jul 22; Vol. 184 (15), pp. 3962-3980.e17. Date of Electronic Publication: 2021 Jun 03.